Wellington Partners
Munich, Germany
Venture capitalSeedSeries ASeries BGrowth
- Ticket size
- Not published
- Activity
- Last deal May 2026
About
European venture capital firm investing in early- and growth-stage life science companies since 1998.
- Headquarters
- Munich, Germany
- Invests in
- Germany, Europe
Last checked 19 November 2026
Industries
- Generalist
- Health
- Biotech
- Industrial tech
Latest deal
May 2026
Nuclidium Series B extension closed (CHF 105m total); portfolio news 2026-11-17 Beren FDA approval
SourceWork at Wellington Partners? Claim this listing to keep it up to date.
Claim this fundSomething wrong or out of date? Tell us and we'll fix it.
Report a mistakeWe list funds from public sources and check each one's website and recent activity. No guarantee of accuracy, and this is not investment advice.